SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A slight decline in the revenue of Rs. 578.29 millions was seen for the September 2023 quarter as against Rs. 605.26 millions during year-ago period.A slender decline of -28.24% was recorded to Rs. 74.72  millions from Rs. 104.12 millions in the corresponding previous quarter.Operating profit for the quarter ended September 2023 decreased to 106.39 millions as compared to 140.23 millions of corresponding quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 578.29 605.26 -4.46 1179.82 1211.23 -2.59 2367.14 2175.84 8.79
Other Income 22.74 11.21 102.85 42.71 14.35 197.63 57.34 34.27 67.32
PBIDT 106.39 140.23 -24.13 212.73 215.15 -1.12 398.85 284.55 40.17
Interest 2.21 0.26 750.00 3.71 0.40 827.50 4.13 2.85 44.91
PBDT 104.18 139.97 -25.57 209.02 180.16 16.02 360.13 281.70 27.84
Depreciation 4.55 2.04 123.04 8.48 3.97 113.60 12.05 15.26 -21.04
PBT 99.63 137.93 -27.77 200.54 176.19 13.82 348.08 266.44 30.64
TAX 24.91 33.81 -26.32 51.03 42.86 19.06 80.87 77.87 3.85
Deferred Tax -0.92 1.43 -164.34 -0.81 -7.36 -88.99 4.56 3.84 18.75
PAT 74.72 104.12 -28.24 149.51 133.33 12.14 267.21 188.57 41.70
Equity 130.99 130.99 0.00 130.99 130.99 0.00 130.99 130.99 0.00
PBIDTM(%) 18.40 23.17 -20.59 18.03 17.76 1.51 16.85 13.08 28.84

Jagsonpal Pharma Share Price

208.80 -4.15 (-1.95%)
16-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1800.65
Dr. Reddys Lab 1277.05
Cipla 1372.75
Zydus Lifesciences 1078.40
Lupin 2277.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: